Registry-listed formulations

metarrestin · mesh:C000633774

Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.

1 source entries across 1 studies. This list may not include all unresolved or historical entries.

  • MetarrestinRegistry intervention

    Linked study entry; product equivalence not established

    View study and source

Success Metrics

Active Trials
1(100%)

Phase Distribution

Phase 1
1
100%

Phase Distribution

1

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution1 total trials
Phase 1Safety & dosage
1(100.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

1

all time

Status Distribution
Active(1)

Detailed Status

Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
1
Active
1
Success Rate
N/A
Most Advanced
Phase 1

Trials by Phase

Phase 11 (100.0%)

Trials by Status

recruiting1100%

Recent Activity

1 active trials
Showing 1 of 1
recruitingphase_1

Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors

NCT04222413

Clinical Trials (1)

Showing 1 of 1 trials
NCT04222413Phase 1

Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors

Recruiting

All 1 trials loaded

Drug Details

Intervention Type
Drug
Total Trials
1